Retraction
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Paper Information
Record ID:
20571
Author(s):
Publication Date:
February 13, 2012
Retraction Date:
June 03, 2019
(6.5 years years ago)
Subjects:
Institutions:
- Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA
- Service d’Hématologie Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
- INSERM U917, Université de Rennes 1, Rennes, France
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA
- Department of Immunobiology, Yale Cancer Center, New Haven, Connecticut, USA
Countries:
Article Type:
Publisher:
American Society of Clinical Investigation
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (113)
113
Total Citations25
Post-Retraction(22.1%)
75
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
7
Within 1 year
14
After 2+ years
1956
Days since retraction (latest)
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Oct 2024
1956 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Aug 2024
1908 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Sep 2023
1558 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Jul 2023
1501 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Apr 2023
1404 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Feb 2023
1360 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Sep 2022
1199 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Sep 2022
1186 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Jun 2022
1110 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: May 2022
1071 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Dec 2021
941 days after retraction
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
Hasan Baysal, Ines De Pauw, Hannah Zaryouh et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Sep 2021
49 citations
49 citations
827 days after retraction
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan et al. (7 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Jul 2021
1819 citations
1819 citations
770 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Jun 2021
746 days after retraction
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Nastaran Hashemzadeh, Mitra Dolatkhah, Khosro Adibkia et al. (7 authors)
Life Sciences
Published: Jan 2021
52 citations
52 citations
603 days after retraction
Paper citing Hydrazinocurcumin Encapsuled Nanoparticles Re-Educ...
Unknown Authors
Unknown Journal
Published: Jan 2021
578 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Sep 2020
480 days after retraction
Harnessing NK Cell Checkpoint-Modulating Immunotherapies
Sachin Kumar Singh Chauhan, Ulrike Koehl, Stephan Kloeß
Cancers
Open Access
Published: Jul 2020
12 citations
12 citations
399 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Apr 2020
305 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Mar 2020
272 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Jan 2020
212 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Nov 2019
162 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Nov 2019
156 days after retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Oct 2019
142 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Jul 2019
28 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: May 2019
18 days before retraction
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
Dinh‐Toi Chu, Nguyen Xuan Bac, Khanh Hoang Nguyen et al. (15 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2019
77 citations
77 citations
52 days before retraction
Paper citing Targeting CD137 enhances the efficacy of cetuximab...
Unknown Authors
Unknown Journal
Published: Mar 2019
88 days before retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Mar 2019
91 days before retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Feb 2019
108 days before retraction
NK cells to cure cancer
Clara Di Vito, Joanna Mikulak, Elisa Zaghi et al. (6 authors)
Seminars in Immunology
Published: Feb 2019
81 citations
81 citations
122 days before retraction
Paper citing Targeting CD137 enhances the efficacy of cetuximab...
Unknown Authors
Unknown Journal
Published: Jan 2019
153 days before retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Dec 2018
172 days before retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Nov 2018
200 days before retraction
Therapeutic blockade of Activin-A improves NK cell function and anti-tumor immunity
Jai Rautela, Laura F. Dagley, Iona S. Schuster et al. (16 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2018
1 citation
1 citation
217 days before retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Sep 2018
266 days before retraction
Paper citing CD137 stimulation enhances the antilymphoma activi...
Unknown Authors
Unknown Journal
Published: Jun 2018
353 days before retraction
Quick Stats
Total Citations:
113
Years Since Retraction:
6.5 years
Open Access:
Yes
Last Checked:
Never